| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
The prospect of marijuana legalization might inspire visions of weed-smoking breaks at work, or grabbing a joint with co-workers after a hectic day at the office.[CR-LF][CR-LF]But the reality of legalization in Illinois will likely be much hazier. Some employers might start turning a blind eye to employee use - as long as workers can still do their jobs - a trend that's already happening in some other states where it's legal. Other employers, however, might still ban its use, taking action against employees who test positive for pot, bolstered by federal law under which marijuana is still illegal, experts say.For example, in Colorado, about 96% of employers who used the drug testing company Quest Diagnostics in 2017 still included marijuana in their employee drug testing, said Dr. Barry Sample, senior director of science and technology for Quest's employers solutions business. In Nevada, where recreational cannabis use is also legal, that number was 91% in 2017.
Steve Rusckowski was appointed CEO of Quest Diagnostics Incorporated. This analysis aims first to contrast CEO compensation with other large companies. After that, we will consider the growth in the business. Third, we'll reflect on the total return to shareholders over three years, as a second measure of business performance. The aim of all this is to consider the appropriateness of CEO pay levels.
Quest Diagnostics Incorporated Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.
Quest Diagnostics announced this week that it is participating in the NCI-Molecular Analysis for Therapy Choice clinical trial as a designated laboratory. The firm said both its Med Fusion 50Seq cancer panel and IBM Watson Genomics from Quest Diagnostics service fulfill the trial's criteria for tumor profiling. Under the terms of the collaboration, when oncologists at participating NCI-MATCH sites order tumor profiling to guide clinical care for their patients, Quest will look for trial matches for the patients.
Blockchain holds much promise for improving data privacy, integrity, and quality, although a lot of companies are taking a wait-and-see approach to the model. Quest Diagnostics is not one of them. The provider of clinical lab services for more than a year has been involved in pilot project with other healthcare companies to apply blockchain technology to improve data quality and reduce administrative costs associated with changes to healthcare provider demographic data.